Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason De Melo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos One|May 21, 2015
Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskJason De Melo, Damu Tang
International Journal of Cell Biology|March 12, 2013
PKM2, a Central Point of Regulation in Cancer MetabolismNicholas Wong, Jason De Melo, Damu Tang
International Journal of Molecular Medicine|July 15, 2014
SIPL1 enhances the proliferation, attachment, and migration of CHO cells by inhibiting PTEN functionJason De Melo, Vincent Wu, Lizhi He, et al.
Cellular Signalling|August 26, 2014
SIPL1-facilitated PTEN ubiquitination contributes to its association with PTENJason De Melo, Xiaozeng Lin, Lizhi He, et al.
Cancer Investigation|June 3, 2014
Changes in PKM2 associate with prostate cancer progressionNicholas Wong, Judy Yan, Diane Ojo, et al.
Molecular Cancer|November 12, 2009
PTEN inhibits BMI1 function independently of its phosphatase activityCatherine Fan, Lizhi He, Anil Kapoor, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 28, 2019
Image-Based Analysis of Protein StabilityK Ashley Hickman, Santosh Hariharan, Jason De Melo, et al.
Oncotarget|October 4, 2014
Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinomaBrianne Hill, Jason De Melo, Judy Yan, et al.
Disease Models & Mechanisms|July 28, 2019
Modelling the MYC-driven normal-to-tumour switch in breast cancerCorey Lourenco, Manpreet Kalkat, Kathleen E Houlahan, et al.
Genes|June 8, 2017
MYC Deregulation in Primary Human CancersManpreet Kalkat, Jason De Melo, Katherine Ashley Hickman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos One|May 21, 2015
Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskJason De Melo, Damu Tang
International Journal of Cell Biology|March 12, 2013
PKM2, a Central Point of Regulation in Cancer MetabolismNicholas Wong, Jason De Melo, Damu Tang
International Journal of Molecular Medicine|July 15, 2014
SIPL1 enhances the proliferation, attachment, and migration of CHO cells by inhibiting PTEN functionJason De Melo, Vincent Wu, Lizhi He, et al.
Cellular Signalling|August 26, 2014
SIPL1-facilitated PTEN ubiquitination contributes to its association with PTENJason De Melo, Xiaozeng Lin, Lizhi He, et al.
Cancer Investigation|June 3, 2014
Changes in PKM2 associate with prostate cancer progressionNicholas Wong, Judy Yan, Diane Ojo, et al.
Molecular Cancer|November 12, 2009
PTEN inhibits BMI1 function independently of its phosphatase activityCatherine Fan, Lizhi He, Anil Kapoor, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 28, 2019
Image-Based Analysis of Protein StabilityK Ashley Hickman, Santosh Hariharan, Jason De Melo, et al.
Oncotarget|October 4, 2014
Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinomaBrianne Hill, Jason De Melo, Judy Yan, et al.
Disease Models & Mechanisms|July 28, 2019
Modelling the MYC-driven normal-to-tumour switch in breast cancerCorey Lourenco, Manpreet Kalkat, Kathleen E Houlahan, et al.
Genes|June 8, 2017
MYC Deregulation in Primary Human CancersManpreet Kalkat, Jason De Melo, Katherine Ashley Hickman, et al.
Pageof 2